ARTICLE | Company News
Amarillo receives Orphan Drug designation
August 22, 2000 7:00 AM UTC
The FDA granted Orphan Drug designation for AMAR's Veldona oral low dose interferon-alpha to treat papillomavirus warts in the oral cavity of HIV positive patients. In February, the FDA granted Orphan...